Title: Sustained-release Nucleic Acid Matrix Compositions
Patent Number: 8,795,726
Filed: Jan. 18, 2011
Lead Inventor: Noam Emanuel, Polypid
Title: Hydrophobic Nanotubes and Nanoparticles as Transporters for the Delivery of Drugs into Cells
Patent Number: 8,795,734
Filed: Aug. 3, 2012
Lead Inventor: Hongjie Dai, Stanford University
Title: Ribonucleic Acid Interference Molecules of Oryza sativa
Patent Number: 8,795,987
Filed: July 31, 2008
Lead Inventor: Tien Huynh, IBM
Title: Primer Extension-based Method for the Generation of siRNA/miRNA Expression Vectors
Patent Number: 8,795,988
Filed: Aug. 15, 2008
Lead Inventor: Lin Liu, Oklahoma State University
Title: RNA Interference-mediating Small RNA Molecules
Patent Number: 8,796,016
Filed: June 21, 2010
Lead Inventor: Thomas Tuschl, Max Planck Institute
Title: Methods for Attenuating Dengue Virus Infection
Patent Number: 8,796,235
Filed: Sept. 10, 2004
Lead Inventor: Shyam Mohapatra, University of South Florida
Title: Short RNA Mimetics
Patent Number: 8,796,238
Filed: Sept. 13, 2010
Inventor: Kevin Forbes, Sigma-Aldrich
Title: siRNA Compounds Comprising Terminal Substitutions
Patent Number: 8,796,239
Filed: Nov. 25, 2010
Inventor: Sharon Avkin-Nachum, Quark Pharmaceuticals
Title: Modified iRNA Agents
Patent Number: 8,796,436
Filed: March 22, 2013
Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals
Title: Combined Hairpin-Antisense Compounds and Methods for Modulating Expression
Patent Number: 8,796,442
Filed: March 20, 2008
Lead Inventor: John Shanklin, Brookhaven National Laboratory
Title: Reduced-size Self-delivering RNAi Compounds
Patent Number: 8,796,443
Filed: Sept. 22, 2009
Lead Inventor: Anastasia Khvorova, RXi Pharmaceuticals
Title: Methods and Compositions for the Specific Inhibition of Gene Expression by Double-stranded RNA
Patent Number: 8,796,444
Filed: July 6, 2011
Lead Inventor: John Rossi, City of Hope